BOC Sciences Makes Possible a Fast Pace of RNA Drug Discovery

BOC Sciences has collaborated with Dr. Shiyue Fang’s team from Michigan Technological University on sensitive DNA/RNA synthesis. Thanks to the long-term dedication, BOC Sciences constructs a full-scale RNA synthesis platform that provides customers with technical support in siRNA design, synthesis, analysis, coupling, and delivery.

New York, USA – February 21, 2022 – BOC Sciences is an ambitious bio-chem company, aiming at offering prime siRNA products and services. It is hailed by many for the all-sided RNAi techniques which have facilitated breakthroughs in RNA therapies. In response to the hurdles pharmaceutical companies frequently encounter, BOC Sciences’ work originates from oligo synthesis to nanoparticle-siRNA conjugation, covering every step indispensable for RNA drug research.

BOC Sciences demonstrates outstanding abilities in oligo synthesis. Its oligo production would undergo sophisticated procedures more than a matter of synthesis, including purification, quality inspection, subpackage, quality reinspection, and delivery. Though the workflow seems time-consuming, BOC Sciences conscientiously persists in the exacting standards to measure up to cGMP regulations.

Concerning the specific strategies at every stage, BOC Sciences implements varieties of techniques accordingly. For the purpose of oligonucleotides customization, it utilizes phosphoramidite solid-phase method that can synthesize oligonucleotides with tailored sequences and achieve scale-up production. Other tactics like mass spectrometry, high-throughput electrophoresis, and HPLC are significant tools to conduct purity control at BOC Sciences.

The naked RNA drugs are prone to degradation owing to the existence of massive RNases in blood, posing great threats to efficient drug delivery. Technicians of BOC Sciences have been grappling with this problem by their intelligence, and eventually established an award-winning drug delivery system. It can provide DOTAP for the preparation of cationic liposomes, the most helpful drug carrier discovered so far with admirable biocompatibility, biodegradability, low toxicity, and non-immunogenicity.

“BOC Sciences has a well-stocked library of drug delivery complexes. In addition to exosomes and liposomes, it also supplies a series of bioconjugates,” the head advisor says. The qualified nanoparticle conjugates characterize BOC Sciences’ superiority in producing bioconjugates, beyond which BOC Sciences also provides customers with professional advice on optimal conjugation options and one-to-one targeted services.

Highlights of BOC Sciences’ RNA products and services:

* Flexible synthesis specifications

* Comprehensive modifications & labeling

* Advanced high-throughput production equipment

* Experienced team

* Competitive price

* Fast delivery

To learn more about BOC Sciences and its RNA Synthesis technologies, please browse https://rna.bocsci.com.

About

BOC Sciences is a trusted contract manufacturing partner providing first-rate RNA products and services. Its sub-brand RNA, specialized in siRNA-related techniques, has propped up many RNA therapeutic programs including the current pressing COVID-19 vaccine research.

Media Contact
Company Name: BOC Sciences
Contact Person: Alex Brown
Email: Send Email
Phone: 1-631-485-4226
Country: United States
Website: https://rna.bocsci.com


Posted

in

by

Tags: